Skip to main content

Recursion Pharmaceuticals, Inc.

RXRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001601830

In the last 90 days, Recursion Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 4 sales; 344 institutions reported holding it in 13F filings for Q2 2026, worth $1.33B in total; ARK Invest is the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Recursion Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
4 filings
2 insiders, $435.0K in total
Insiders trading
2
Net value
−$435.0K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Recursion Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Recursion Pharmaceuticals, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Taylor Ben RChief Financial Officer1,071,462Sep 16, 202612
Khan NajatCEO and President2,072,890Sep 10, 202610
Borgeson BlakeDirector6,158,287Sep 2, 202611
Hallett DavidChief Scientific Officer1,043,837Aug 18, 20264
Dar ZavainDirector240,764Jul 2, 20265
Li Dean YDirector1,473,329Jul 2, 20265
Hershberg RobertDirector162,156Jun 22, 20261
Sun Elaine DDirector135,981Jun 22, 20261
Michor FranziskaDirector215,477Jun 22, 20261
Bumpus NamandjeDirector127,632Jun 22, 20262
Gibson ChristopherDirector883,735Jun 5, 202618
Mauro David JChief Medical Officer225,429Nov 19, 20240
Secora MichaelChief Financial Officer1,487,694Nov 19, 20240
Larson Tina MarriottPresident and COO506,852Nov 19, 20240
Burrell Terry-AnnDirector71,254Jul 3, 20240
Chavez R. MartinDirector60,078Apr 3, 20240
Virani ShafiqueChief Business Officer136,748Jan 18, 20240
Bogue ZacharyDirector, 10% Owner9,378Jul 6, 20230
Mamoura Diversified Global Holding PJSC10% Owner12,985,927IndirectMar 3, 20230
Mubadala Investment Co PJSC10% Owner12,985,927IndirectMar 3, 20230
Doyle RamonaChief Medical Officer121,110May 18, 20220
Lux Ventures IV, L.P.Other: Former 10% Owner13,021,519Dec 9, 20210
Lux Venture Partners IV, LLCOther: Former 10% Owner13,021,519Dec 9, 20210
Hebert PeterOther: Former 10% Owner13,021,519Dec 9, 20210
Lux Co-Invest Partners, LLCOther: Former 10% Owner13,021,519Dec 9, 20210
Lux Co-Invest Opportunities, L.P.Other: Former 10% Owner13,021,519Dec 9, 20210
Wolfe JoshOther: Former 10% Owner13,021,519Dec 9, 20210
Mic Capital Partners (Public) (US) Im, LLCOther: See remarks–Nov 3, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 28, 2023 (view filing)Jan 5, 2022478 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−18.5K$7.39−$136.7K−3.1%582.8K afterAmended
May 5, 2023 (view filing)May 32 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−33.1K$4.71−$155.8K−3.4%953.2K after
May 5, 2023 (view filing)May 32 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−25.0K$4.90−$122.6K−100.0%0 after3 lots
May 17, 2023 (view filing)May 161 dayBorgeson BlakeDirectorSSaleClass A Common Stock−8.88K$5.09−$45.2K−0.1%7.55M after
Jun 1, 2023 (view filing)May 302 daysBorgeson BlakeDirectorSSaleClass A Common Stock−8.88K$8.79−$78.1K−0.1%7.54M after
Jun 2, 2023 (view filing)May 312 daysLarson Tina MarriottPresident and COOSSaleClass A Common Stock−3.00K$8.63−$25.9K−0.7%424.2K after
Jun 5, 2023 (view filing)Jun 1-24 daysVirani ShafiqueChief Business OfficerSSaleClass A Common Stock−42.9K$8.73−$374.0K−22.9%144.0K after2 lots10b5-1
Jun 9, 2023 (view filing)Jun 72 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−56.4K$9.05−$510.7K−5.8%916.4K after
Jun 15, 2023 (view filing)Jun 13-142 daysSecora MichaelChief Financial OfficerSSaleClass A Common Stock−50.0K$10.00−$500.0K−5.8%817.9K after2 lots10b5-1
Jun 15, 2023 (view filing)Jun 132 daysBorgeson BlakeDirectorSSaleClass A Common Stock−15.5K$9.98−$154.5K−0.2%7.53M after
Jun 20, 2023 (view filing)Jun 15-165 daysVirani ShafiqueChief Business OfficerSSaleClass A Common Stock−60.0K$9.54−$572.4K−29.4%144.0K after2 lots10b5-1
Jun 29, 2023 (view filing)Jun 272 daysBorgeson BlakeDirectorSSaleClass A Common Stock−8.88K$7.39−$65.7K−0.1%7.53M after
Jul 3, 2023 (view filing)Jun 294 daysLarson Tina MarriottPresident and COOSSaleClass A Common Stock−3.00K$7.49−$22.5K−0.7%424.2K after10b5-1
Jul 13, 2023 (view filing)Jul 112 daysBorgeson BlakeDirectorSSaleClass A Common Stock−8.88K$6.89−$61.2K−0.1%7.52M after
Jul 14, 2023 (view filing)Jul 12-132 daysBurrell Terry-AnnDirectorSSaleClass A Common Stock−117.0K$12.07−$1.41M−68.1%54.8K after5 lots
Jul 14, 2023 (view filing)Jul 122 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−31.8K$13.14−$418.0K−3.4%915.8K after4 lots
Jul 14, 2023 (view filing)Jul 122 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−25.0K$11.77−$294.2K−100.0%0 after13 lots
Jul 19, 2023 (view filing)Jul 17-182 daysVirani ShafiqueChief Business OfficerSSaleClass A Common Stock−60.0K$12.73−$763.8K−29.4%144.0K after2 lots10b5-1
Jul 19, 2023 (view filing)Jul 18-191 daySecora MichaelChief Financial OfficerSSaleClass A Common Stock−50.0K$14.58−$729.0K−5.6%842.9K after5 lots10b5-1
Jul 27, 2023 (view filing)Jul 252 daysBorgeson BlakeDirectorSSaleClass A Common Stock−18.7K$14.61−$273.5K−0.2%7.49M after
Jul 27, 2023 (view filing)Jul 25-262 daysVirani ShafiqueChief Business OfficerSSaleClass A Common Stock−40.0K$14.36−$574.2K−21.7%144.0K after2 lots10b5-1
Jul 28, 2023 (view filing)Jul 271 dayLarson Tina MarriottPresident and COOSSaleClass A Common Stock−8.00K$13.63−$109.0K−1.9%424.2K after2 lots10b5-1
Aug 4, 2023 (view filing)Aug 22 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−65.0K$13.04−$847.9K−6.8%890.7K after2 lots
Aug 10, 2023 (view filing)Aug 82 daysBorgeson BlakeDirectorSSaleClass A Common Stock−17.8K$11.16−$198.4K−0.2%7.47M after2 lots
Aug 17, 2023 (view filing)Aug 15-162 daysSecora MichaelChief Financial OfficerSSaleClass A Common Stock−50.0K$9.09−$454.3K−5.5%863.2K after2 lots10b5-1
Aug 17, 2023 (view filing)Aug 152 daysVirani ShafiqueChief Business OfficerSSaleClass A Common Stock−18.0K$9.25−$166.5K−11.4%140.4K after10b5-1
Aug 24, 2023 (view filing)Aug 222 daysBorgeson BlakeDirectorSSaleClass A Common Stock−8.88K$8.91−$79.2K−0.1%7.46M after
Aug 28, 2023 (view filing)Aug 244 daysLarson Tina MarriottPresident and COOSSaleClass A Common Stock−3.00K$8.66−$26.0K−0.7%418.8K after2 lots10b5-1
Sep 7, 2023 (view filing)Sep 52 daysBorgeson BlakeDirectorSSaleClass A Common Stock−8.88K$8.79−$78.1K−0.1%7.45M after
Sep 8, 2023 (view filing)Sep 62 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−33.8K$8.78−$296.5K−3.7%871.3K after
Sep 8, 2023 (view filing)Sep 62 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−25.0K$8.83−$220.8K−100.0%0 after3 lots
Sep 14, 2023 (view filing)Sep 12-132 daysSecora MichaelChief Financial OfficerSSaleClass A Common Stock−50.0K$8.56−$428.0K−5.3%888.2K after2 lots10b5-1
Sep 19, 2023 (view filing)Sep 154 daysVirani ShafiqueChief Business OfficerSSaleClass A Common Stock−18.0K$8.66−$155.9K−11.4%140.4K after10b5-1
Sep 21, 2023 (view filing)Sep 192 daysBorgeson BlakeDirectorSSaleClass A Common Stock−8.88K$8.36−$74.3K−0.1%7.44M after
Oct 2, 2023 (view filing)Sep 284 daysLarson Tina MarriottPresident and COOSSaleClass A Common Stock−3.00K$7.72−$23.2K−0.7%418.8K after10b5-1
Oct 5, 2023 (view filing)Oct 32 daysBorgeson BlakeDirectorSSaleClass A Common Stock−8.88K$7.29−$64.8K−0.1%7.43M after
Oct 6, 2023 (view filing)Oct 42 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−59.8K$7.21−$431.1K−6.6%842.7K after
Oct 12, 2023 (view filing)Oct 10-112 daysSecora MichaelChief Financial OfficerSSaleClass A Common Stock−50.0K$6.96−$348.0K−5.2%913.2K after2 lots10b5-1
Oct 18, 2023 (view filing)Oct 162 daysVirani ShafiqueChief Business OfficerSSaleClass A Common Stock−18.0K$6.30−$113.4K−11.4%140.4K after10b5-1
Oct 19, 2023 (view filing)Oct 172 daysBorgeson BlakeDirectorSSaleClass A Common Stock−8.88K$6.58−$58.5K−0.1%7.43M after
Oct 30, 2023 (view filing)Oct 264 daysLarson Tina MarriottPresident and COOSSaleClass A Common Stock−3.00K$5.63−$16.9K−0.7%418.8K after10b5-1
Nov 2, 2023 (view filing)Oct 312 daysBorgeson BlakeDirectorSSaleClass A Common Stock−8.88K$5.27−$46.8K−0.1%7.42M after
Nov 3, 2023 (view filing)Nov 12 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−37.2K$5.20−$193.3K−4.3%836.8K after
Nov 3, 2023 (view filing)Nov 12 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−25.0K$5.12−$127.9K−100.0%0 after3 lots
Nov 16, 2023 (view filing)Nov 14-152 daysSecora MichaelChief Financial OfficerSSaleClass A Common Stock−50.0K$6.82−$341.0K−5.1%938.2K after3 lots10b5-1
Nov 16, 2023 (view filing)Nov 142 daysBorgeson BlakeDirectorSSaleClass A Common Stock−8.88K$6.32−$56.2K−0.1%7.41M after
Nov 17, 2023 (view filing)Nov 152 daysVirani ShafiqueChief Business OfficerSSaleClass A Common Stock−18.0K$6.51−$117.2K−11.4%140.4K after10b5-1
Nov 17, 2023 (view filing)Nov 161 dayLarson Tina MarriottPresident and COOSSaleClass A Common Stock−3.00K$6.76−$20.3K−0.7%413.4K after10b5-1
Nov 30, 2023 (view filing)Nov 282 daysBorgeson BlakeDirectorSSaleClass A Common Stock−11.4K$6.72−$76.9K−0.2%7.40M after10b5-1
Dec 8, 2023 (view filing)Dec 62 daysGibson ChristopherChief Executive OfficerSSaleClass A Common Stock−59.8K$7.49−$448.1K−7.0%791.3K after